The 14th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) aims to promote and enhance the development of novel technologies and treatments for diabetes and strives to change the lives of people with diabetes.
Bruce Bode, MD, of Atlanta Diabetes Associates will present clinical research findings as part of the Virtual Poster Sessions.
Hospitalized type 1 diabetes patients (T1D), with Covid-19, with and without diabetic ketoacidosis (DKA) had similar outcomes using an electronic glycemic management system eGMS
Bruce Bode, MD | Atlanta Diabetes Associates
Jordan Messler, MD, SFHM, FACP | Glytec
Robert Booth | Glytec
John Clarke, RN, CDE | Glytec
You Might Also Like